Scuderi P E, MacGregor D A, Bowton D L, James R L
Department of Anesthesia (Section on Critical Care), Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina 27157-1009.
Anesthesiology. 1994 Jul;81(1):245-53. doi: 10.1097/00000542-199407000-00031.
Measurement of mixed venous hemoglobin oxygen saturation via catheters employing reflectance spectrophotometry has been available for more than 10 yr. Despite numerous clinical reports that have presented data showing the poor accuracy of these devices when used clinically, they are still widely used in clinical care. The reason for lack of agreement with measurements made using bench spectrophotometry is unclear. The purpose of this study is to define the performance limitations of three hemoglobin oxygen saturation catheters (Oximetrix 3, SAT-2, and HEMOPRO2) in a controlled laboratory environment using a blood flow loop primed with fresh whole human blood as a model. Our hypothesis is that the performance limitations of these devices represent inherent limitations in the technology, not error introduced by patient anatomy and physiology.
Blood was equilibrated in a flow loop to four analytic gas mixtures designed to achieve oxygen saturation of approximately 50%, 60%, 70%, and 80%, respectively, with carbon dioxide tension, pH, and temperature held constant. Saturation readings from the catheters were collected on-line by microcomputer. Periodic blood samples were withdrawn from the flow loop for analysis on a bench spectrophotometer and subsequent comparison with catheter-derived values.
By all measures, performances of the Oximetrix 3 and SAT-2 systems were comparable (all data are presented as percent saturation unless otherwise noted); bias +/- precision was 3.20 +/- 2.47 and -1.25 +/- 3.36, respectively, versus -9.97 +/- 7.05 for the HEMOPRO2. The 95% confidence limits based on intracatheter variability were +/- 3.49, +/- 2.90, and +/- 9.13 for the Oximetrix 3, SAT-2, and HEMOPRO2, respectively. The 95% confidence limits based on total variability, although similar for Oximetrix 3 (+/- 4.83) and SAT-2 (+/- 6.59), were larger for the HEMOPRO2 (+/- 13.82). The 95% confidence intervals for agreement between catheter brands were -2.14, 11.04 (Oximetrix 3 - SAT-2); -0.18, 26.52 (Oximetrix 3 - HEMOPRO2) and -5.24, 22.68 (SAT-2 - HEMOPRO2).
While the Oximetrix 3 and SAT-2 may be acceptable as continuous monitors used to detect changes or trends, none of the three systems is equivalent to conventional bench oximetry for the measurement of hemoglobin oxygen saturation.
通过采用反射分光光度法的导管测量混合静脉血红蛋白氧饱和度已有10多年历史。尽管有大量临床报告提供的数据显示这些设备在临床使用时准确性较差,但它们仍广泛应用于临床护理。与台式分光光度法测量结果不一致的原因尚不清楚。本研究的目的是在可控的实验室环境中,以用新鲜全血灌注的血流回路为模型,确定三种血红蛋白氧饱和度导管(Oximetrix 3、SAT - 2和HEMOPRO2)的性能局限性。我们的假设是,这些设备的性能局限性代表了该技术的固有局限性,而非患者解剖结构和生理因素引入的误差。
在血流回路中将血液平衡至四种分析气体混合物,分别设计为使氧饱和度达到约50%、60%、70%和80%,同时保持二氧化碳分压、pH值和温度恒定。通过微型计算机在线收集导管的饱和度读数。定期从血流回路中抽取血样,在台式分光光度计上进行分析,并随后与导管得出的值进行比较。
从各方面衡量,Oximetrix 3和SAT - 2系统的性能相当(除非另有说明,所有数据均以饱和度百分比表示);偏差±精密度分别为3.20±2.47和 - 1.25±3.36,而HEMOPRO2为 - 9.97±7.05。基于导管内变异性的95%置信限,Oximetrix 3、SAT - 2和HEMOPRO2分别为±3.49、±2.90和±9.13。基于总变异性的95%置信限,虽然Oximetrix 3(±4.83)和SAT - 2(±6.59)相似,但HEMOPRO2更大(±13.82)。导管品牌之间一致性的95%置信区间为 - 2.14, 11.04(Oximetrix 3 - SAT - 2); - 0.18, 26.52(Oximetrix 3 - HEMOPRO2)和 - 5.24, 22.68(SAT - 2 - HEMOPRO2)。
虽然Oximetrix 3和SAT - 2作为用于检测变化或趋势的连续监测器可能是可接受的,但这三种系统中没有一种在测量血红蛋白氧饱和度方面等同于传统的台式血氧测定法。